HEART FAILURE
Clinical Overview

Investigational Pharmacological Strategies

 

---

 

¹ Sackner-Bernstein FD, Mancini DM. Rationale for treatment of patients with chronic heart failure with adrenergic blockade. JAMA 1995;274:1462-1467.

² Goodfriend TL, Elliott ME, Catt KJ. Drug therapy: Angiotensin receptors and their antagonists. NEJM 1996;33:1649-1654.

³ Munger MA, Furniss SM. Angiotensin II receptor blockers: novel therapy for heart failure? Pharmacotherapy 1996;16(2 Pt 2):59S-68S.

⁴ Diuretics and Cardiovasculars. In: Drug Facts and Comparisons. Cada DJ, Hussar DA et al, editors. Facts and Comparisons Inc. J.B. Lippincott Co., St. Louis, Missouri 1998.135-172p.

⁵ Pieper JA. Evolving role of calcium channel blockers in heart failure. Pharmacotherapy 1996; 16(2 Pt 2):43S-49S.

⁶Tresch DD, McGough MF. Heart failure with normal systolic function: a common disorder in older people. JAGS 1995;43:1035-1042.

⁷ Braun S et al. Calcium antagonists and mortality in patients with coronary artery disease: a cohort study of 11,575 patients. JACC 1996;28:7-11.

⁸ Messerli FH. Whatever happened to the calcium antagonist controversy? JACC 1996;28:12-13.

⁹ ,O'Connor CM, Gattis WA, Swedberg K. Current and novel pharmacologic approaches in advanced heart failure. Am Heart J 1998;135:S249-S263.

return to top